Gly-Sal 2-2 Pads

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Gly-Sal 2-2 Pads
Generic name: SALICYLIC ACID
Manufacturer: Topiderm, Inc.
Product type: HUMAN OTC DRUG
SPL set ID: a92a9ffb-5c5b-43a4-b669-04667324920b
SPL ID: 45299656-b734-4edb-a780-e99a5a333043
Version: 2
Effective date: 2023-02-16
Source export date: 2026-09-28
Source partition: 3
Source file: https://download.open.fda.gov/drug/label/drug-label-0003-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/fd09911bd1bc81f7f2faeb048e63855fe224e494376ae919a0035190e315c050/drug-label-0003-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:17:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Gly-Sal 2-2 Pads	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Topiderm, Inc.	openfda.manufacturer_name
ndc	package	51326-923-01	openfda.package_ndc
ndc	product	51326-923	openfda.product_ndc
ndc11	package	51326092301	derived:openfda.package_ndc
rxcui		797892	openfda.rxcui
spl id		45299656-b734-4edb-a780-e99a5a333043	id
spl set id		a92a9ffb-5c5b-43a4-b669-04667324920b	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Keep away from eyes, lips, and mouth Keep out of reach of children If irritation develops, discontinue use and consult a doctor Using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor If swallowed, seek professional assistance or contact a Poison Control Center immediately Sunscreen use is recommended with any glycolic acid product and for an additional week thereafter because some individuals may be more sensitive to sunlight.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.